A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer diseaseStephen Salloway, Michael Grundman, Nick C. Fox et al.|Neurology|2009Cited by 739
A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer diseaseStephen Salloway, Reisa A. Sperling, Ron Keren et al.|Neurology|2011Cited by 255